Evidence-Based Oncology | September

Evidence-Based Oncology

Michael E. Chernew, PhD; Lee N. Newcomer, MD, MHA; and Sandra M. Swain, MD; examine the treatment benefits, cost concerns, and insurance coverage strategies for pertuzumab.
Targeted Therapies to Further Improve Outcomes

More issues

Feature
Diabetes Compendium
Oncology Compendium
COPD Compendium
Reimbursement Compendium
HF Compendium
$vacMongoViewPlus$